You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Therapeutic efficacy and safety of long-term stored hemoglobin-vesicles in a rat model of hemorrhagic shock
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-C-035-Tuesday
- By: TOKUNO, Masahiro (Sojo University, Kumamoto, Japan)
- Co-author(s): Masahiro Tokuno: Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan
Kazuaki Taguchi: Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan
Keishi Yamasaki: Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan;DDS Research Institute, Sojo University, Kumamoto, Japan
Hiromi Sakai: Department of Chemistry, Nara Medical University, Nara, Japan
Masaki Otagiri: Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan;DDS Research Institute, Sojo University, Kumamoto, Japan - Abstract:
Backgrounds
Hemoglobin-vesicles (HbV) have been developed as red blood cell (RBC) substitutes. In vitro experiments showed that HbV suspensions are structurally and physicochemically stabile for a year, which indicate that HbV can be stored for more than 1 year. However, it remains unclear that long-term stored HbV administration could effectively.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026